Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program

Since it's introduction in 1979 at the University of Massachusetts Medical Center by Dr. Jon Kabat-Zinn, Mindfulness-Based Stress Reduction (MBSR) has become a respected adjunct to conventional treatment for patients suffering from many diverse chronic ailments. Three decades of research have documented it's benefits, but few papers have focused on identifying which particular aspect of MBSR directly correlates with it's degree of therapeutic efficacy. This study will use 7 well validated questionnaires to compare participants responses prior to, and following completion of an eight-week MBSR program at the North York General Hospital, as well as follow-up results at 1 month and 1 year post completion of the MBSR group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Anxiety Disorders Back Pain Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Diabetes Diabetes Mellitus Endocrine System Diseases Fibromyalgia Glucose Metabolism Disorders Headache Disorders Headache Disorders, Primary Hypertension Mental Disorders Metabolic Diseases Migraine Disorders Muscular Diseases Musculoskeletal Diseases Neoplasms Nervous System Diseases Neurologic Manifestations Neuromuscular Diseases Nutritional and Metabolic Diseases Pain Pathological Conditions, Signs and Symptoms Rheumatic Diseases Signs and Symptoms Somatoform Disorders Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

About this study

As above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

over 18 years old
suffer from a chronic health problem
referred by their physician

Exclusion criteria

acute illness (physical or psychiatric)
suicidal
problem use of alcohol or other substances
inability to do one hour of daily homework
inability to attend all 8 sessions

Treatment and study plan

Teaching Mindfulness-based Stress Reduction strategies

Behavioral

Daily meditation, Hatha yoga,and cognitive restructuring

Other names: MBSR

Primary outcomes

PSS-10

Time frame: baseline, 8 weeks and follow-ups at 1 month and 1 year

Patients' Stress Scores on the PSS-10 are used to assess self-reported perceptions of stress at baseline, at 8 weeks when the intervention ends, and again at one month and one year follow-up (to see if any change is sustained).

Secondary outcomes

Toronto Mindfulness Scale (TMS)

Time frame: Baseline, 8 weeks and follow up at 1 month and 1 year

Measure of patients' self-reported capacity for detached curiosity / decentering (aspects of mindfulness), prior to intervention, at the end of the intervention (8 weeks), and at short-term (one month)and long-term (one year) follow-up.

Sponsors and collaborators

Lead sponsor

North York General Hospital

Other

Registry information

Acronym: mbsr

Important dates

Study start: 2009
Primary completion: 2012
Study completion: 2012
First posted: May 15, 2012
Registry last updated: May 15, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed